Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

NCT03442972 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: Teduglutide
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]